Kaye Spratt
About Kaye Spratt
Kaye Spratt serves as the Senior Vice President at Bridgebio and Abeona Therapeutics Inc., with extensive experience in regulatory and quality roles in the biotechnology sector.
Work at BridgeBio
Kaye Spratt has served as Senior Vice President at BridgeBio since 2019. In this role, she has been involved in advancing the company's mission to develop transformative medicines for genetic diseases. Her tenure at BridgeBio is marked by a focus on strategic leadership and regulatory affairs, contributing to the company's growth and innovation in the biotechnology sector.
Work at Abeona Therapeutics Inc.
Kaye Spratt holds the position of Senior Vice President, Regulatory at Abeona Therapeutics Inc. since 2018. Prior to this role, she served as Vice President of Regulatory and Quality at the same company starting in 2015. Her responsibilities include overseeing regulatory strategies and ensuring compliance with industry standards, which are crucial for the development and approval of therapeutic products.
Background in Biotechnology
Before her current roles, Kaye Spratt worked at Sangamo Therapeutics for 17 years, where she held the position of Director. She also served as Director of Preclinical and Assay Development during her 16-year tenure at the company. Her extensive experience in biotechnology has equipped her with a deep understanding of regulatory processes and product development.
Education and Expertise
Kaye Spratt studied Microbiology at Meharry Medical College from 1974 to 1979. This educational background has provided her with a solid foundation in the biological sciences, which she has applied throughout her career in various leadership roles within the biotechnology and pharmaceutical industries.